We destroyed nearly 8,000 packs of expired Orkambi stock last year, Vertex tells UK MPs
To the horror of UK cystic fibrosis patients, a Vertex executive disclosed on Wednesday that last year close to 8,000 packs (each containing a 28-day supply) of Orkambi were destroyed after crossing their expiry date. The US drugmaker has been locked in negotiation with NICE, which has refused to allow the drug in to England’s National Health Service until Vertex offers it a discount on the treatment’s price tag that would compel the agency to look favorably upon its cost-effectiveness.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.